Live Breaking News & Updates on Limmatech biologics

Stay informed with the latest breaking news from Limmatech biologics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Limmatech biologics and stay connected to the pulse of your community

Vaccines in Development

Vaccines in Development
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Austria , Chile , Switzerland , India , Oswaldo-cruz , Rio-grande-do-sul , Brazil , Australia , Denmark , United-states , Sweden , Santiago

Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion)

/PRNewswire/ -- Novo Holdings today announced its financial results for 2023*. Strong Investment Portfolio performance, and growth of the Novo Group companies...

Denmark , United-states , Copenhagen , Køavn- , Wuxi , Jiangsu , China , Singapore , Hong-kong , America , Danish , Limmatech-biologics

LimmaTech Biologics Reports Positive Interim Phase I/II Clinical Data on Tetravalent Shigella Bioconjugate Vaccine S4V

SCHLIEREN, Switzerland, February 22, 2024--LimmaTech Biologics AG announced positive interim data from its Phase I/II clinical trial evaluating Shigella4V (S4V), a tetravalent bioconjugate vaccine candidate against shigellosis, an infectious disease caused by Shigella bacteria. Shigellosis is a serious infection and remains the second leading cause of fatal diarrheal disease, particularly in infants in low- and middle-income countries. In the nine-month-old target population, administration of S

Kenya , United-kingdom , Switzerland , Limmatech-biologics , Alexander-siebert , Patricia-martin , Franz-werner-haas , Network-meeting , Trophic-communications , Wellcome , Chief-operating-officer , Annual-network-meeting

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion In Listeria Monocytogenes Treatment Sector Predicted Amid Risi...

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion In Listeria Monocytogenes Treatment Sector Predicted Amid Risi...
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Dublin , Ireland , United-states , America , Bristol-myers-squibb , Laura-wood , Aurobindo-pharma , Fresenius-kabi , Limmatech-biologics , Eli-lilly , Glaxosmithkline , Regeneron-pharmaceuticals-inc

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence

/PRNewswire/ -- The "Listeria Monocytogenes Infections Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The...

United-states , Dublin , Ireland , America , Bristol-myers-squibb , Eli-lilly , Laura-wood , Aurobindo-pharma , Limmatech-biologics , Fresenius-kabi , Amneal-pharmaceuticals , E-st-office-hours-call

Antimicrobial Resistance Multiple Threats, Multiple Responses

Antimicrobial Resistance Multiple Threats, Multiple Responses
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Kenya , Helsinki , Eteläuomen-läi , Finland , Greece , Finnish , Kenyan , Greek , Patricia-martin , Paul-garofolo , Lyndsay-meyer , Sam-sihvonen

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Australia , Australian , Franz-werner-haas , Paul-wolfrom , Alexander-siebert , Nicola-forrest , Limmatech-biologics , Steve-burnell , Stefan-klotter , Trophic-communications , Impact-fund , Novo-holdings

LimmaTech Biologics Raises Additional $3M in Series A

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Switzerland , Limmatech-biologics , Franz-werner-haas , Novo-holdings , Impact-fund , Adjuvant-capital ,

LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc's Innovative Vaccine Candidate Against Staphylococcus aureus

LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc's Innovative Vaccine Candidate Against Staphylococcus aureus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Germany , Sudan , Gretchen-schweitzer , Javad-aman , Franz-werner-haas , Limmatech-biologics , Michael-kowarik , National-institutes-of-health , Biomedical-advanced-research , Development-authority , Impact-fund

Vaccine profiles: Shigella

Reports of dysentery go back to ancient times, however it was only in the 19th Century that we discovered the bacteria behind it: Shigella. New vaccines on the horizon could have a huge impact in the lower-income countries where this deadly disease predominantly thrives.

Japan , Switzerland , Greece , Japanese , Swiss , Greek , Kiyoshi-shiga , Limmatech-biologics , Vaccine-alliance , World-health-organization , Century-japan , Ancient-greek